Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Behavioural and psychological symptoms of dementia are distressing for patients and are frequently treated with second-generation antipsychotics. Concerns about the drugs' safety resulted in a Medicines and Healthcare Products Regulatory Agency (MHRA) warning against their use in March 2009.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Public Health (Oxf)

Title: Journal of public health (Oxford, England)

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1741-3850

ISSN (Print): 1741-3842

Publication date (Electronic): Jun 2015

Volume: 37

Issue: 2

Affiliations

[1 ] School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

[2 ] School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK.

Article

Publisher Item ID: fdu023

DOI: 10.1093/pubmed/fdu023

PubMed ID: 24681910

SO-VID: c5109700-b36e-4bcd-892e-ea00ae2ef401

History

Keywords: mental health

Data availability:

Keywords: mental health

Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.

Read this article at

Abstract

Related collections

Stigmatisation of mental illnesses

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 6